Imaging evaluation of tumor angiogenesis

CHEN Bo,XU Jian,LU Guang-ming
DOI: https://doi.org/10.3969/j.issn.1008-8199.2011.02.021
2011-01-01
Abstract:Tumor growth depends on angiogenesis,and therefore anti-angiogenesis has been widely used in the treatment of tumors.Microvessel density(MVD) is taken as the "golden standard" for assessing angiogenesis,though it has pitfalls in clinical practice.Routine imaging methods can neither reflect the real condition of tumor angiogenesis nor objectively evaluate the clinical effect of the anti-angiogenetic therapy.The authors reviewed the related literature and,based on the clinical experience,analyzed various imaging methods for assessing tumor angionenesis,including tumor angiography,double energy CT enhancement,CT perfusion,MR perfusion and MR diffuse weighted imaging(DWI),MR blood oxygen level dependent imaging(BOLD),ultrasonic strategies(such as Doppler blood flow imaging,color Doppler energetic imaging,and ultrasonic contrast enhancement),PET/SPECT,and optic imaging.Molecular imagery approaches to vascularization have developed rapidly.Each method is unique for its imaging mechanism,features and applicability.In clinical practice,we should choose among all these techniques the most suitable one to avaluate the effect of anti-angiogenetic therapy.
What problem does this paper attempt to address?